Oral Aripiprazole as Maintenance Treatment in Adolescent Schizophrenia: Results From a 52-Week, Randomized, Placebo-Controlled Withdrawal Study.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American Academy of Child and Adolescent Psychiatry"
DOI: 10.1016/j.jaac.2017.06.013
Abstract: OBJECTIVE To evaluate the efficacy, safety, and tolerability of aripiprazole, a dopamine D2 receptor partial agonist, as maintenance treatment in adolescent outpatients with schizophrenia. METHOD This was a multicenter, double-blind, placebo-controlled, randomized withdrawal design trial.… read more here.
Keywords: placebo; maintenance treatment; maintenance; oral aripiprazole ... See more keywords